Dr Bobby Green on How Flatiron Is Working to Improve Care Delivery
December 23rd 2017Bobby Green, MD, MSCE, senior vice president of clinical oncology at Flatiron Health, discusses analyzing patient data to improve the overall care delivery and its challenges involved with being so early in the process.
Watch
Dr Todd Hobbs Discusses Identifying and Removing Barriers to Care for Obesity
December 21st 2017Although patients and physicians both recognize the need to discuss obesity, the lack of resources, time, and expertise often prevents physicians for offering care and patients from asking for it, explained Todd Hobbs, MD, Novo Nordisk’s vice president and chief medical officer.
Watch
Tesh Khullar on the Importance of Community Oncology Patients Being Involved in Clinical Trials
December 19th 2017Community oncologists face a challenge in getting patients into clinical trials, but new technology could help them get access to those trials, explained Tesh Khullar, senior vice president of provider solutions at Flatiron Health.
Watch
Dr Amy Abernethy on Improving Data Usage at the Point of Care
December 16th 2017Data needs to be more organized so it is more available and useful at the point of care, said Amy Abernethy, MD, PhD, the chief medical officer, chief scientific officer, and senior vice president of oncology at Flatiron Health.
Watch
Dr Todd Hobbs Discusses the Advantages of Semaglutide in Type 2 Diabetes
December 5th 2017On December 5, 2017, FDA approved Novo Nordisk’s semaglutide, a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes. Todd Hobbs, MD, Novo Nordisk’s vice president and chief medical officer, spoke with The American Journal of Managed Care® just ahead of FDA’s action.
Watch
Dr Eliot A. Brinton: Perspectives on PCSK9 Inhibitors
December 1st 2017Results from the FOURIER trial have provided convincing data that there is no downside to aggressively lowering cholesterol with PCSK9 inhibitors, and studies have shown there are cardiovascular benefits associated with Repatha, but reimbursement remains challenging, said Eliot A. Brinton, MD, FAHA, FNLA, president of the Utah Lipid Center.
Watch
The Impact of Medicaid 2.0: A Blueprint for the Future
November 30th 2017Linda Schwimmer, president and CEO of the New Jersey Health Care Quality Institute, discusses the impact of the group’s report, Medicaid 2.0, which outlined how the state can bring healthcare transformation principles to a program that consumes a fifth of the state budget. New Jersey elected a new governor in November, and the blueprint was widely seen a policy recommendation for the next administration.
Watch
A Modern Cholesterol Test: Clinical Advances and Patient Convenience
November 25th 2017A non-fasting test to measure low-density lipoprotein (LDL) cholesterol has many advantages for patients and physicians, but payers can also see some benefits, explained Eliot A. Brinton, MD, FAHA, FNLA, president of the Utah Lipid Center.
Watch
Nat Turner Discusses the Challenges of Using Real-World Data in Clinical Trials
November 22nd 2017Real-world evidence isn't usually used for regulatory decisions, but the FDA is poised to start using it more, and there are challenges to using real-world data in clinical trials that will need to be navigated, said Nat Turner, co-founder and CEO of Flatiron Health.
Watch
Dr Amy Abernethy on Improving Patient Access to Oncology Clinical Trials
November 14th 2017As oncology moves toward more deep diagnostic testing and as standard of care continues to quickly evolve, technology advancements are necessary to continue to improve patient access to clinical trials, explained Amy Abernethy, MD, PhD, the chief medical officer, chief scientific officer, and senior vice president of oncology at Flatiron Health.
Watch
Dr Peter Aran on How to Improve Quality Measure Decisions
November 13th 2017New approaches for measuring quality need to be developed to get frontline caregivers involved in the early stages of quality measure decisions, said Peter Aran, MD, medical director of population health management at Blue Cross Blue Shield of Oklahoma.
Watch
Tesh Khullar: Community Oncologists Need to Understand Impact of Biosimilars on Their Business
November 8th 2017Biosimilars for core therapeutics in cancer are starting to come out, and community oncologists need to understand what that means for their business, as well as what proposed policy changes could mean for reimbursement, explained Tesh Khullar,
Watch
Dr Paul Chew: Employers Need to Embrace Diabetes Prevention in the Workplace
November 3rd 2017With 30% to 40% of people in the workforce at risk for prediabetes, it is important for employers to embrace diabetes prevention in the workplace, said Paul Chew, MD, chief medical officer of Omada Health.
Watch
Linda Schwimmer Outlines New Jersey's Efforts to Better Understand Impact of New Payment Models
November 3rd 2017New Jersey is 1 of 3 states that will test a new set of metrics to assess how well new payment models have penetrated markets, explained Linda Schwimmer, JD, president and CEO of the New Jersey Health Care Quality Institute, which will lead the process in New Jersey.
Watch
Aaron Lyss: Most Practices Are Not Ready to Transition to MACRA
October 31st 2017Most practices are not ready to transition to the Medicare Access and CHIP Reauthorization Act (MACRA) payment models, although there is a leading group of practices that are more prepared to make the switch, said Aaron Lyss, director of value-based care for Tennessee Oncology.
Watch
Dr Charlie Fazio: Partnerships Needed to Address Social Determinants of Health
October 31st 2017Clinicians have some influence over social determinants that affect the health of patients, but it’s important for partnerships to be developed to further improve the negative impacts of certain determinants, said Charlie Fazio, MD, senior vice president and medical director of HealthPartners.
Watch
Teri Kovach on What to Do During an EMR Disruption
October 25th 2017A practice must be prepared for any disruption of the electronic medical record, and have a plan in place, even if it doesn't occur often, saidTeri Kovach, RN, OCN, compliance officer and charge nurse at Salish Cancer Center.
Read More
Dr Bobby Green: How Technology Can Help Clinicians Make Decisions
October 20th 2017While technology and electronic health records will one day be used in a variety of ways can help improve the delivery of care to patients, this may take a long time, said Bobby Green, MD, MSCE, senior vice president of clinical oncology at Flatiron Health.
Watch
Brian Marcotte Gives Recommendations for Employers Considering ACOs
October 17th 2017Brian Marcotte, president and CEO of the National Business Group on Health, offers recommendations for employers that are considering accountable care organizations (ACOs) and describes situations when an ACO is not a good fit.
Watch
Dr Leora Horn on How Biosimilar Pegfilgrastim Could Improve Patient Access
October 16th 2017Cost will be one of the most important factors to determine whether or not a biosimilar pegfilgrastim improves patient access to the treatment, said Leora Horn, MD, clinical director of thoracic oncology at Vanderbilt-Ingraham Cancer Center, assistant vice chancellor for faculty development at Vanderbilt University Medical Center.
Watch
Kim Woofter on How Data Will Change Care Delivery in the Next 5 Years
October 15th 2017Value-based care will start to transition from being an option to being a requirement, and better data will be needed to improve how care is delivered to patients, said Kim Woofter, executive vice president of strategic alliances and practice innovation at the Advanced Centers for Cancer Care.
Watch